1. BOVILIS BVD contains the equivalent of 7.7 log10 TCID50 per dose of cytopathogenic BVD virus strain C86.
2. The virus is grown in cell culture and inactivated with beta-propiolactone.
3. The antigen is adsorbed onto an aluminium salts adjuvant.
4. The vaccine contains methyl parahydroxybenzoate as a preservative and traces of antibiotics and calf serum as residues of the antigen production.
Aqueous suspension for injection.
Cattle from eight months of age onwards.
For the active immunisation of cattle against BVDV, and in cows and heifers, against transplacental infection of the foetus with BVDV.
a) Individual vaccination
Two doses with an interval of 4 weeks.
The second dose should be given no less than 4 weeks before the start of gestation.
One dose 4 weeks before the start of the next gestation.
b) Herd vaccination
Two doses with an interval of 4 weeks for all cattle over eight months of age.
One dose every 6 months.
Foetal protection can be expected if the primary immunisation has been completed 4 weeks before the start of gestation. It is advisable to vaccinate breeding bulls at the same time as the rest of the herd.
Method of administration
By intramuscular injection.
None. (National regulations should be observed).
20 ml multi dose glass vials.
Store in the dark between 2-8°C. Do not freeze.
1. Before use, allow the vaccine to reach the ambient temperature (15-25°C).
2. Shake well before use.
3. Use sterile syringes and needles.
4. Animals vaccinated less than 4 weeks before the start of gestation or during early gestation will not
5. Protected against foetal infection before the next gestation period.
6. Do not mix with other vaccines.
7. Do not administer in conjunction with other parenteral products.
8. Contra-indications – Broached vials should be used within 10 hours (one working day).
1. Do not mix with other vaccines.
2. Do not vaccinate sick or weak animals.
A slight swelling may be observed for 14 days at the injection site.